Grandstanding
Without Results
By
Phil Mattera in the Dirt Diggers Digest
Members
of Congress subjected the CEOs of a pair of a pair of rogue corporations
to much-deserved castigation in recent days, but the executives will probably
turn out to be the victors.
John Stumpf of Wells Fargo and Heather Bresch of Mylan endured the barbs knowing that they will not lead to any serious consequences.
John Stumpf of Wells Fargo and Heather Bresch of Mylan endured the barbs knowing that they will not lead to any serious consequences.
The
periodic grilling of business moguls amid corporate scandals is a longstanding
feature of Congressional oversight.
In the 1930s the Senate Banking Committee, led by investigator Ferdinand Pecora, questioned Wall Street titans such as J.P. Morgan about the causes of the stock market crash.
In the 1930s the Senate Banking Committee, led by investigator Ferdinand Pecora, questioned Wall Street titans such as J.P. Morgan about the causes of the stock market crash.
In the late 1950s Sen.
Estes Kefauver asked pharmaceutical executives about rising drug prices. In the
1960s Sen. Abraham Ribicoff, with the help of a young lawyer named Ralph Nader,
interrogated auto industry executives about their seemingly cavalier attitude
toward safety.
Jumping
to the recent past: In 2010 the CEO of BP was hauled before a House hearing to
testify about the Deepwater Horizon disaster.
In 2013 the Senate’s Permanent Subcommittee on Investigations questioned Apple CEO Tim Cook about his company’s international tax avoidance. And so forth.
In 2013 the Senate’s Permanent Subcommittee on Investigations questioned Apple CEO Tim Cook about his company’s international tax avoidance. And so forth.
Yet there is a big difference between the older and the more recent hearings. In the 20th Century these events were preludes to legislative reform. The Pecora hearings led to the passage of the Glass-Steagall Act separating speculative activities from commercial banking.
Kefauver tried but failed to pass price
restrictions but was able to enact stricter drug manufacturing and reporting
rules. The Ribicoff hearings led to the passage of the National Traffic and
Motor Vehicle Safety Act and the Highway Safety Act.
Those
earlier hearings may have been political theatre, but they were followed by
serious regulatory changes. Today’s hearings, on the other hand, seem to be
nothing more than theatre. For many members of Congress, they are opportunities
to pretend to be concerned about corporate misconduct while having no intention
to do anything about it.
That’s
not surprising, given that the party in control of both chambers of Congress is
rabidly anti-regulation. The 2016 Republican National Platform is filled with critical comments about
regulation, including an assertion that the Obama Administration “triggered an
avalanche of regulation that wreaks havoc across the economy.”
The
Consumer Financial Protection Bureau, the lead regulator in the Wells Fargo fake
accounts case, is a favorite target of conservative lawmakers. Right after the
CFPB’s Wells Fargo announcement, Speaker Paul Ryan sent out
a tweet claiming that the agency “tries to micromanage your everyday life.”
Senate Banking Committee Chair Richard Shelby tried to block the appointment of
Richard Cordray to head the CFPB and subsequently sought to weaken the agency.
And during his opening statement at the hearing, he took a pot shot at
CFPB for not being aggressive enough in pursuing the case.
Congressional
grandstanding against corporate miscreants has been going on for decades, but
what was once a device to build public support for real legislative change now
serves mainly to conceal the fact that too many legislators are in office to do
the bidding of corporations, even the most corrupt ones.